REPARRIS
Live / Applied — Third extension granted (statement of use) (as of 04 Mar 2026)
What this means for you
Not registered yet, but its 24 Aug 2023 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98149201
- Mark type
- Stylized text
- Filed
- 24 Aug 2023
- Published for opposition
- 28 May 2024
- Attorney of record
- Perry J. Viscounty
Goods and services
- Class 042 — Scientific and technological services: Pharmaceutical research and development; Research and development in the pharmaceutical and biotechnology fields; Research and development in the field of regenerative medicine; Development of therapeutics and cell therapies; Development of pharmaceutical preparations and medicines for treating pain, arthritis, fibrosis, orthopedic disorders, inflammatory disorders and musculoskeletal disorders
Owner
- ReParris, Inc., Lancaster, CA, US
- ReParris, Inc., Lancaster, CA, US
Prosecution history
- 04 Mar 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 04 Mar 2026 — SOU EXTENSION 3 GRANTED
- 23 Jan 2026 — SOU EXTENSION 3 FILED
- 04 Mar 2026 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 30 Jan 2026 — SOU EXTENSION RECEIVED WITH TEAS PETITION
- 30 Jan 2026 — NOTICE OF REVIVAL - E-MAILED
- 30 Jan 2026 — PETITION TO REVIVE-GRANTED
- 30 Jan 2026 — TEAS PETITION TO REVIVE RECEIVED
- 19 Jul 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 18 Jul 2025 — SOU EXTENSION 2 GRANTED
- 18 Jul 2025 — SOU EXTENSION 2 FILED
- 18 Jul 2025 — SOU TEAS EXTENSION RECEIVED
- 04 Mar 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 23 Jan 2025 — SOU EXTENSION 1 GRANTED
- 23 Jan 2025 — SOU EXTENSION 1 FILED